Premium
Janux Therapeutics Inc (JANX)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| RA Capital Management, L.P. | Institution | 11 189 693 | 18,35% | US$ 153,97M | 2026-03-31 |
| RA Capital Healthcare Fund, L.P. | Institution | 10 141 287 | 16,63% | US$ 139,54M | 2025-06-11 |
| BlackRock, Inc. | Institution | 5 433 053 | 8,91% | US$ 74,76M | 2026-03-31 |
| Janus Henderson Group plc | Institution | 4 196 409 | 6,88% | US$ 57,74M | 2026-03-31 |
| Prosight Management, LP | Institution | 3 550 000 | 5,82% | US$ 48,85M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 3 069 759 | 5,03% | US$ 42,24M | 2026-04-28 |
| Paradigm BioCapital International Fund Ltd. | Institution | 3 030 509 | 4,97% | US$ 41,70M | 2024-12-31 |
| Klaus Dorner | Initiés | 2 999 990 | 4,92% | US$ 41,28M | 2025-02-15 |
| FMR LLC | Institution | 2 535 683 | 4,16% | US$ 34,89M | 2026-03-31 |
| Adage Capital Partners, L.P. | Institution | 2 525 000 | 4,14% | US$ 34,74M | 2025-06-30 |
| State Street Global Advisors, Inc. | Institution | 2 464 017 | 4,04% | US$ 33,90M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 811 365 | 2,97% | US$ 24,92M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 1 789 617 | 2,93% | US$ 24,63M | 2026-03-31 |
| Alyeska Investment Group, L.P. | Institution | 1 601 089 | 2,63% | US$ 22,03M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 1 597 650 | 2,62% | US$ 21,98M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 1 290 256 | 2,12% | US$ 17,75M | 2026-03-31 |
| Deep Track Capital, LP | Institution | 1 187 290 | 1,95% | US$ 16,34M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 1 146 724 | 1,88% | US$ 15,78M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 1 090 147 | 1,79% | US$ 15,00M | 2026-03-31 |
| RA Capital Nexus Fund II, L.P. | Institution | 1 048 406 | 1,72% | US$ 14,43M | 2025-06-11 |
| Logos Global Management, L.P. | Institution | 1 000 000 | 1,64% | US$ 13,76M | 2026-03-31 |
| Citadel Multi-Strategy Equities Master Fund Ltd. | Institution | 999 606 | 1,64% | US$ 13,75M | 2024-09-30 |
| OrbiMed Advisors LLC | Institution | 983 600 | 1,61% | US$ 13,53M | 2026-03-31 |
| Avalon Ventures XI | Institution | 925 088 | 1,52% | US$ 12,73M | 2024-11-06 |
| Nantahala Capital Management, LLC | Institution | 809 914 | 1,33% | US$ 11,14M | 2026-03-31 |
| Irenic Capital Management LP | Institution | 765 804 | 1,26% | US$ 10,54M | 2026-03-31 |
| Woodline Partners LP | Institution | 738 032 | 1,21% | US$ 10,16M | 2026-03-31 |
| Prosight Plus Fund, LP | Institution | 685 220 | 1,12% | US$ 9,43M | 2026-02-03 |
| Bank of America Corporation | Institution | 674 761 | 1,11% | US$ 9,28M | 2026-03-31 |
| Morgan Stanley | Institution | 664 056 | 1,09% | US$ 9,14M | 2026-03-31 |
| Squarepoint OPS LLC | Institution | 604 000 | 0,99% | US$ 8,31M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 504 654 | 0,83% | US$ 6,94M | 2026-03-31 |
| Tang Capital Management, LLC | Institution | 500 000 | 0,82% | US$ 6,88M | 2026-03-31 |
| Algert Global LLC | Institution | 443 397 | 0,73% | US$ 6,10M | 2026-03-31 |
| Millennium Management LLC | Institution | 386 810 | 0,63% | US$ 5,32M | 2026-03-31 |
| Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A. | Institution | 376 496 | 0,62% | US$ 5,18M | 2026-03-31 |
| Rock Springs Capital Management LP | Institution | 367 009 | 0,60% | US$ 5,05M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
